Psychopharmakologie vertiefen und CME‑Credits erwerben

Sparen Sie Zeit und bleiben Sie in der Psychopharmakologie auf dem neuesten Stand.

Praktische Tipps

Monatliche Updates

Wählen Sie Ihren Lernstil

Vergessen Sie kommerzielle Einflussnahme

Unsere 10 Lieblingsthemen: Empfehlungen der Redaktion

Video, Text und Audio

Management of Delirium – Scott R. Beach, M.D.

The Psychopharmacology Algorithm for Psychotic Depression – David Osser, M.D.

Medicinal Cannabis and the Psychiatric Patient: Clinical Harm vs Novel Treatment – Diana Martinez, M.D.

Antipsychotic Switching: Intersection of Art and Science – Brian Miller, M.D., Ph.D., M.P.H.

Use of Psychotropics in Patients With Hepatic Issues – Jonathan M. Meyer, M.D.

Audio und Text

Psychosis and Schizophrenia in Children and Adolescents – David R. Rosenberg, M.D.

The Clinical Guide to Adult ADHD – Oscar G. Bukstein, M.D., M.P.H.

The Psychopharmacology of Feeding and Eating Disorders – Timothy Brewerton, M.D., D.L.F.A.P.A., F.A.E.D., D.F.A.A.C.A.P., C.E.D.S.-S.

What Clinicians Need to Know About Alcohol Use Disorder – Joji Suzuki, M.D.

Obsessive-Compulsive and Related Disorders – Robert Hudak, M.D.

Lesen, hören oder schauen Sie kurze Videos in Häppchenform.

Mehr als 2 Stunden monatliche Psychopharm-Updates, plus sofortiger Zugriff auf unser Archiv mit mehr als 90 Stunden.

Video Lectures: Lernen neu gedacht

Kurze Videos, um Ihre Verordnungskompetenz zu aktualisieren. Enthält Kernpunkte, die die praktischsten Tipps zusammenfassen.

David Osser, M.D.

University of California, San Diego

Expert Consultations: Antworten aus der Praxis

Wir interviewen Expertinnen und Experten, die klinische Perlen für Ihren anspruchsvollen Praxisalltag teilen.

Pharmakotherapie der schwer behandelbaren Depression

Ein Gespräch mit Dr. Thase, das die gesamte therapeutische Hierarchie der behandlungsresistenten Depression durchgeht: von der Wahl des ersten Antidepressivums über die Entscheidung zwischen Wechsel und Augmentation bis zu Antipsychotika der zweiten Generation, psychiatrischen Komorbiditäten und interventionellen Optionen.

Prof. Michael E. Thase, M.D.

Perelman School of Medicine, University of Pennsylvania

Flavio Guzmán, M.D.

Psychopharmacology Institute

Liste der Video Lectures ansehen, die sofort verfügbar sind

Themen
Fakultät
Pharmakotherapie der chronischen Insomnie: Ein praktischer Leitfaden

Bhanu Prakash Kolla, M.D.

Professor of Psychiatry um Mayo Clinic

Psychopharmaka bei medizinisch komplexen Patienten: Was Kliniker wissen müssen

Siobhan Gee, M.Pharm., P.G.Dip., M.R.Pharm.S., Ph.D.

Deputy Director of Pharmacy & Consultant Pharmacist for Liaison Psychiatry um South London and Maudsley NHS Foundation Trust

PTSD-Psychopharmakologie-Algorithmus

David Osser, M.D.

Associate Professor of Psychiatry um Harvard Medical School

Quick Takes: Forschung, auf den Punkt gebracht

Fünf Forschungszusammenfassungen zur Erwachsenenpsychiatrie – jeden Monat.

Quick Take Vol. 87

Welches Antipsychotikum sollten Sie für eine Frau mit einer Erstpsychose wählen? Was funktioniert tatsächlich bei therapieresistenter Schizophrenie, wenn Clozapin keine Option ist? Verändern Missbrauchsdaten aus der Praxis Ihre Auswahl bei Insomnia-Medikamenten? Übertraf serielles Ketamin Midazolam in einer neuen stationären Studie? Kann eine anhaltende Anthocyanin-Zufuhr die Kognition verbessern?

Amanda Koire, M.D., Ph.D.

Brigham and Women's Hospital – Harvard Medical School

Oliver Freudenreich, M.D., F.A.C.L.P.

Massachusetts General Hospital – Harvard Medical School

David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M.

University of Maryland School of Medicine

James Phelps, M.D.

Psychopharmacology Institute

Derick E. Vergne, M.D.

Tufts University School of Medicine

Brain Guides: gezielter verordnen

Verordnungsleitfäden: jedes Medikament, seine Nebenwirkungen und die Neuerungen, die seinen Einsatz verändern.

Ketamin-Leitfaden: Pharmakologie, Indikationen, Dosierungsempfehlungen und Nebenwirkungen

Ein umfassender Leitfaden zu Ketamin in der Psychiatrie: die schnellen antidepressiven Wirkmechanismen, der Off-Label-Einsatz bei behandlungsresistenter Depression und Suizidalität, die Dosierungsschemata, die Pharmakokinetik, die Arzneimittelinteraktionen, die Nebenwirkungen und die Besonderheiten bei speziellen Patientengruppen.

Sebastián Malleza, M.D.

Psychopharmacology Institute

Ketamin: Vorteile und Nachteile, Zusammenfassung des Brain Guide
Quick Takes für den sofortigen Zugriff
Information

Quick Take Vol. 90

Amanda Koire, M.D., Ph.D., Scott R. Beach, M.D., Oliver Freudenreich, M.D., F.A.C.L.P., Derick E. Vergne, M.D.

Quick Take Vol. 89

Scott R. Beach, M.D., James Phelps, M.D., Oliver Freudenreich, M.D., F.A.C.L.P., Derick E. Vergne, M.D., David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M.

Quick Take Vol. 88

Scott R. Beach, M.D., James Phelps, M.D., Oliver Freudenreich, M.D., F.A.C.L.P., Derick E. Vergne, M.D., Paul Zarkowski, M.D.

Quick Take Vol. 87

Amanda Koire, M.D., Ph.D., Oliver Freudenreich, M.D., F.A.C.L.P., David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M., James Phelps, M.D., Derick E. Vergne, M.D.

Quick Take Vol. 86

Amanda Koire, M.D., Ph.D., James Phelps, M.D., Oliver Freudenreich, M.D., F.A.C.L.P., Paul Zarkowski, M.D., David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M.

Quick Take Vol. 85

Oliver Freudenreich, M.D., F.A.C.L.P., Paul Zarkowski, M.D., James Phelps, M.D., Scott R. Beach, M.D., David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M.

Quick Take Vol. 84

Scott R. Beach, M.D., Oliver Freudenreich, M.D., F.A.C.L.P., Derick E. Vergne, M.D., Paul Zarkowski, M.D., James Phelps, M.D.

Quick Take Vol. 83

Oliver Freudenreich, M.D., F.A.C.L.P., Scott R. Beach, M.D., Paul Zarkowski, M.D., James Phelps, M.D., Derick E. Vergne, M.D.

Quick Take Vol. 82

Oliver Freudenreich, M.D., F.A.C.L.P., Scott R. Beach, M.D., David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M., Paul Zarkowski, M.D., Derick E. Vergne, M.D.

Quick Take Vol. 81

Oliver Freudenreich, M.D., F.A.C.L.P., Scott R. Beach, M.D., Kristin Raj, M.D., Paul Zarkowski, M.D., David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M.
Liste der Quick Takes 2026-27 ansehen
Erscheinungsdatum
Information

Keine Daten gefunden

Hören Sie alle Inhalte unserer Website über einen Audio Feed

Sehen Sie sich unsere kommenden Updates für 2026–2027 an

Keine Daten gefunden

Preise

Sofortigen Zugriff erhalten

Wählen Sie eine Mitgliedschaft – jederzeit kündbar.

Bronze-Mitgliedschaft

€199

(EUR) /year

Bronze wählen
  • Bis zu 47 CMEs
  • 12 neue CMEs pro Jahr
  • Unbegrenzte Downloads

  • Video Lectures
    Treatment updates, as bite-sized videos.
  • Expert Consultations
    Clinical pearls from interviews with experts.
  • Quick Takes
    Research summaries in adult psychiatry.
  • CAP Smart Takes
    Research summaries in child and adolescent psychiatry.
  • Brain Guides
    Practical guides for decision-making in psychopharmacology.
  • Audio Feed
    Listen to our website content on your podcasting app.
  • Self-Assessment Credits
    U.S. psychiatrists need 16 SAs for MOC. We offer 40 SAs.

Silver-Mitgliedschaft

Bester Wert

€229

(EUR) /year

Silver wählen
  • Bis zu 115 CMEs
  • 30 neue CMEs pro Jahr
  • Unbegrenzte Downloads

  • Video Lectures
    Treatment updates, as bite-sized videos.
  • Expert Consultations
    Clinical pearls from interviews with experts.
  • Quick Takes
    Research summaries in adult psychiatry.
  • CAP Smart Takes
    Research summaries in child and adolescent psychiatry.
  • Brain Guides
    Practical guides for decision-making in psychopharmacology.
  • Audio Feed
    Listen to our website content on your podcasting app.
  • Self-Assessment Credits
    U.S. psychiatrists need 16 SAs for MOC. We offer 40 SAs.

Bronze-Mitgliedschaft

20% RABATT

€796

(EUR) /5 Jahre

Bronze wählen
  • Bis zu 47 CMEs
  • 12 neue CMEs pro Jahr
  • Unbegrenzte Downloads

  • Video Lectures
    Treatment updates, as bite-sized videos.
  • Expert Consultations
    Clinical pearls from interviews with experts.
  • Quick Takes
    Research summaries in adult psychiatry.
  • CAP Smart Takes
    Research summaries in child and adolescent psychiatry.
  • Brain Guides
    Practical guides for decision-making in psychopharmacology.
  • Audio Feed
    Listen to our website content on your podcasting app.
  • Self-Assessment Credits
    U.S. psychiatrists need 16 SAs for MOC. We offer 40 SAs.

Silver-Mitgliedschaft

20% RABATT

€916

(EUR) /5 Jahre

Silver wählen
  • Bis zu 115 CMEs
  • 30 neue CMEs pro Jahr
  • Unbegrenzte Downloads

  • Video Lectures
    Treatment updates, as bite-sized videos.
  • Expert Consultations
    Clinical pearls from interviews with experts.
  • Quick Takes
    Research summaries in adult psychiatry.
  • CAP Smart Takes
    Research summaries in child and adolescent psychiatry.
  • Brain Guides
    Practical guides for decision-making in psychopharmacology.
  • Audio Feed
    Listen to our website content on your podcasting app.
  • Self-Assessment Credits
    U.S. psychiatrists need 16 SAs for MOC. We offer 40 SAs.

Heute sind Video Lectures, Quick Takes und Brain Guides auf Deutsch verfügbar. Die übrigen Inhalte Ihrer Mitgliedschaft sind auf Englisch und werden nach und nach übersetzt.

CME Information

Physicians – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medical Academy, LLC designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Download Accreditation Information (PDF)

Nursing professionals – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medical Academy, LLC designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The ANCC accepts AMA PRA Category 1 Credit(s)™ as Contact Hours, under this calculation: 1 CME = 1 Contact Hour. 

All of our content is psychopharmacology, so the pharmacology hours shown on your certificate match the credits awarded for that activity. Your certificate states them on their own line, separately from the credit designation statement.

This applies to APRN pharmacology renewal as well. Boards of nursing define pharmacology CE in their own way, so please confirm with your board that this is the documentation they expect.

Download Accreditation Information (PDF)

Physician assistants – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medical Academy, LLC designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The NCCPA accepts AMA PRA Category 1 Credit™ from providers accredited by the ACCME toward PA certification maintenance. Requirements are set by the NCCPA, so please confirm with them what your current cycle requires.

Download Accreditation Information (PDF)

Physicians outside the United States – CME Accreditation Statement

AMA PRA Category 1 Credit™ may be awarded to any physician, whether or not they are licensed in the United States. The requirements are the same.

The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMEC®s) should contact the UEMS at mutualrecognition@uems.eu.

Whether these credits count toward your own national continuing education requirement is decided by your national medical chamber or society, and the rules differ from country to country. We recommend confirming with them before relying on the credits for a licensing or recertification requirement.

Self Assessment for MOC – Accreditation Statement
  • Psychopharmacology Institute Self-Assessment Program 2026

Dates: April 1, 2026 – April 1, 2029

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2026 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

  • Psychopharmacology Institute Self-Assessment Program 2025

Dates: April 1, 2025 – April 1, 2028

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2025 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

  • Psychopharmacology Institute Self-Assessment Program 2024

Dates: April 1, 2024 – April 1, 2027

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2024 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

Unsere Experten: Fachleute mit praktischer Erfahrung

David R. Rosenberg, M.D.

Chair of the Department of Psychiatry & Behavioral Neuroscience

Wayne State University School of Medicine

Robert Hudak, M.D.

Professor of Psychiatry

University of Pittsburgh

Lauren Osborne, M.D.

Vice Chair of Clinical Research in the Department of Obstetrics and Gynecology

Weill Cornell Medicine

Diana Martinez, M.D.

Professor of Psychiatry

Columbia University Irving Medical Center

Brian Miller, M.D., Ph.D., M.P.H.

Professor of Psychiatry

Medical College of Georgia Augusta University

David Osser, M.D.

Associate Professor of Psychiatry

Harvard Medical School

Vivien K. Burt, M.D., Ph.D.

Professor Emeritus of Psychiatry & Founder and Consulting Director

David Geffen School of Medicine at UCLA & Women’s Life Center of the Resnick UCLA Neuropsychiatric Hospital

Scott R. Beach, M.D.

Associate Professor of Psychiatry

Harvard Medical School

Jonathan M. Meyer, M.D.

Assistant Clinical Professor of Psychiatry

University of California San Diego

Was Klinikerinnen und Kliniker sagen

Es ist schön, aktuelle Informationen zu verfügbaren pharmakologischen Behandlungen an einem Ort zu haben. Die Tutorials sind kurz, aber voller notwendiger Informationen.

Claudia Cuervo, M.D.

Ihre Algorithmen sind eine großartige Ressource für Lehre und Konsultation

Matthew Goodwin, M.D.